Effectiveness of magnesium isoglycyrrhizinate on perioperative hepatic function protection in patients undergoing hepatectomy

Figure 2 The proportion of patients with postoperative liver injury. A: The proportion of patients with postoperative liver injury who received perioperative magnesium isoglycyrrhizinate vs those who received postoperative magnesium isoglycyrrhizinate only; B-D: Changes in serum alanine aminotransferase (ALT); E-G: Changes in serum aspartate aminotransferase (AST) levels. Postoperative liver injury is defined as ≥ 3 × upper limit of normal of the serum ALT or AST levels. Group number: A2-2 means prophylaxis group in which patients were treated with perioperative magnesium isoglycyrrhizinate plus postoperative other liver protectants; B2-2 means non-prophylaxis group in which patients were treated with postoperative magnesium isoglycyrrhizinate plus postoperative other liver protectants. ^aP < 0.05. ^bP < 0.01. ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; POD: Postoperative day; NS: Not significant.